Physician profile
Donald H Lee
NPI 1346337482
$545,631.31
in general payments reported to CMS, 2019-2025
6 companies · $81K in 2025
The $81K reported for 2025 was more than what 99% of Hand Surgery providers received nationally (typical 2025 total: $270).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $70K · 2020: $63K · 2021: $83K · 2022: $78K · 2023: $87K · 2024: $83K · 2025: $81K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $244K · Consulting Fee: $5,900 · Travel and Lodging: $1,122 · Food and Beverage: $495.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $243,784.44 |
| Consulting Fee | $5,900.00 |
| Travel and Lodging | $1,121.98 |
| Food and Beverage | $494.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $531,385.03 | 2019-2025 | Ncb, Nexgen, Dvr Anatomic Kickstand |
| Endo Pharmaceuticals INC. | $13,485.09 | 2019-2023 | Xiaflex |
| Pharmaceutical Business Consultants Limited | $400.00 | 2020 | |
| Acera Surgical, INC. | $136.79 | 2024 | Restrata Wound Matrix |
| Axogen | $128.58 | 2025 | |
| Bone Support INC. | $95.82 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Donald Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.